Two Case Reports of Moderate covid-19 With Chronic Co-Morbidities Treated Through Ayurveda Medicines
DOI:
https://doi.org/10.22270/ajprd.v13i6.1675Abstract
COVID-19 or SARS-COV-2 is caused due to the strain of corona virus characterized by respiratory and other systemic illness such as cough, sore throat, breathlessness, fever, tiredness, loss of taste and smell, myalgia, diarrhea, abdominal pain.It is a medical public health emergency declared by WHO in January 2020. As such no specific treatment is available for this disease.Symptomatic and supportive treatment like antiviral, corticosteroids, anticoagulants,vitamin supplements and mechanical ventilation are applied in conventional treatment.Ayurveda science also offers measures the patient to relieve symptoms as well as cure the asymptomatic patient or patient with mild symptoms. The patients who get the severe illness with co-morbidity requires tertiary care from the beginning itself but can also be co-prescribed with Ayurveda medicines in order to reduce the mortality and to buy the more time to have intensive management. The authors reportedtwo moderate cases of COVID-19 having one or more chronic co-morbidities treated successfully with Ayurvedic therapeutic approach. Significant improvements were noticed in the symptoms like fever, breathlessness, cough & lethargy after Ayurvedic treatment was added. Both of the patients got the negative result of SARS-COV-2 by the 10th day of the ayurvedic treatment though both of them had co-morbidities. One had hypertension and cardiac arrhythmia while another one had bronchial asthma.
Downloads
References
https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-managementpatients.
html Accessed on 16 July 2020
Sun YJ, Feng YJ, Chen J, Li B, Luo ZC, Wang PX. Clinical features of fatalities in patients with COVID-19. Disaster Med Public Health Prep. Jul 15:1-10. Doi:10.1017/dmp.2020.235. PMID:32665052.
Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J et al. Clinical radiological and laboratory characteristics and risk factors for severityand mortality of 289 hospitalized COVID-19 patients. Allergy, 2020 Jul 14. Doi: 10.1111/all.14496. PMID: 32662525
Bhagyalakshmi B R, Galib R, Prajapati P K. Critical Review of Shwasakuthar Rasa - A Herbomineral formulation. International Journal of Ayurvedic Medicine, 2015, 6(3), 206-211.
Salil K. Bhattacharya, D. Bhattacharya, K. Sairam, S. Ghosal. Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia. Phytomedicine, 9: 167-170, 2002.
Rasatantra Sara Evam Siddha Yoga Samgraha Prathama Khanda, Kharaliya Rasayana-32, 19th edition, Krishnagopal Ayurveda Bhavan, 2010; 181.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Miti Virani

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.